The reduction or removal of blast percentage thresholds in recent AML classifications, including the ICC and WHO frameworks, reflects the recognition that MECOM-rearranged myeloid neoplasms exhibit aggressive biology and a high propensity for leukemic transformation, even at low blast counts [2,32,33]. The gene discussed is MECOM; the disease is myeloid neoplasm.